Academic literature on the topic 'Extrusion-spheronization'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Extrusion-spheronization.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Extrusion-spheronization"

1

Jain, Satishkumar P., Pirthi Pal Singh, and Purnima D. Amin. "Alternative extrusion–spheronization aids." Drug Development and Industrial Pharmacy 36, no. 11 (June 3, 2010): 1364–76. http://dx.doi.org/10.3109/03639045.2010.482590.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Zhang, Rui Shi, J. Z. Pan, and L. W. Wang. "Manufacture of Fine AL2O3 Granules as Catalyst Carrier by an Extrusion/Spheronization Method." Advanced Materials Research 44-46 (June 2008): 361–66. http://dx.doi.org/10.4028/www.scientific.net/amr.44-46.361.

Full text
Abstract:
The effect of formulation (filler’s kind and amount, liquid’s kind and concentration required for granulation) and spheronization time on characterization of alumina based pellets parameters (pellets size distribution, roundness and aspect ratio) were investigated. Two schemes were successfully proofed by extrusion/spheronization. The mean volume particle diameter was found to have a profound effect on the formulation and processing parameters. Alumina powder with large mean volume particle diameter showed different mechanism of action with coupling agent. With the surface modification, the water required for granulation had decreased. The existing formal and kinematic velocity of the water had a direct effect on the processing parameter of the extrusion and spheronization. Spheronization time from 2 to 10 min had a pronounced effect on roundness and aspect ratio. No changes in roundness and aspect ratio were observed from 10 to 20 min of spheronization time.
APA, Harvard, Vancouver, ISO, and other styles
3

Santoso, Rahmat, and Fiqi Aliudin. "KAJIAN PUSTAKA FORMULASI DAN EVALUASI MIKROKAPSUL SALUT ENTERIK MENGGUNAKAN ACRYL-EZE® & SURETERIC DENGAN METODE PENGGABUNGAN MIKROENKAPSULASI DENGAN EKSTRUSI-SFERONISASI." Jurnal Riset Kefarmasian Indonesia 2, no. 3 (September 15, 2020): 122–36. http://dx.doi.org/10.33759/jrki.v2i3.89.

Full text
Abstract:
Microcapsules were prepared by means of microencapsulation modified by the extrusion-spheronization method. The extrusion-spheronization method is used to cover the shortcomings of the microencapsulation method. The results showed that Acryl-eze and Sureterik can be used in coatings in producing microcapsules. The results of research evaluating the formulation of enteric acetosal coated microcapsules have not resulted in delayed release system that is in accordance with monographic requirements and dissolution profile testing has not shown the elimination stage. The results of the evaluation of the delayed release release system enteric coated microcapsule formulation met the requirements of monograph and dissolution profile test results, except for F3 in buffering conditions. The purpose of this literature review is to examine the enteric-coated microcapsule formulation using Acryl-eze® & Sureteric by combining microencapsulation and spheronization extrusion methods.
APA, Harvard, Vancouver, ISO, and other styles
4

Sinha, Vivek Ranjan, M. K. Agrawal, A. Agarwal, Gurpreet Singh, and D. Ghai. "Extrusion-Spheronization: Process Variables and Characterization." Critical Reviews™ in Therapeutic Drug Carrier Systems 26, no. 3 (2009): 275–331. http://dx.doi.org/10.1615/critrevtherdrugcarriersyst.v26.i3.20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

GOSKONDA, S., G. HILEMAN, and S. UPADRASHTA. "Controlled release pellets by extrusion-spheronization." International Journal of Pharmaceutics 111, no. 1 (October 6, 1994): 89–97. http://dx.doi.org/10.1016/0378-5173(94)90405-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Iyer, R. M., L. L. Augsburger, D. G. Pope, and R. D. Shah. "Extrusion/Spheronization—Effect of Moisture Content and Spheronization Time on Pellet Characteristics." Pharmaceutical Development and Technology 1, no. 4 (January 1996): 325–31. http://dx.doi.org/10.3109/10837459609031427.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

M. P., Gowrav, Umme Hani, Hosakote G. Shivakumar, Riyaz Ali M. Osmani, and Atul Srivastava. "Polyacrylamide grafted guar gum based glimepiride loaded pH sensitive pellets for colon specific drug delivery: fabrication and characterization." RSC Advances 5, no. 97 (2015): 80005–13. http://dx.doi.org/10.1039/c5ra17257h.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Steckel, H., and F. Mindermann-Nogly. "Production of chitosan pellets by extrusion/spheronization." European Journal of Pharmaceutics and Biopharmaceutics 57, no. 1 (January 2004): 107–14. http://dx.doi.org/10.1016/s0939-6411(03)00156-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Jadhav, Namdeo, Preeti Irny, Ashwini Mokashi, Pravin Souche, and Anant Paradkar. "Pelletization by Extrusion Spheronization Technique: An Excipient Review." Drug Delivery Letterse 2, no. 2 (July 1, 2012): 132–45. http://dx.doi.org/10.2174/2210303111202020132.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jadhav, Namdeo, Preeti Irny, Ashwini Mokashi, Pravin Souche, and Anant Paradkar. "Pelletization by Extrusion Spheronization Technique: An Excipient Review." Drug Delivery Letters 2, no. 2 (July 1, 2012): 132–45. http://dx.doi.org/10.2174/2210304x11202020132.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Extrusion-spheronization"

1

Fielden, Krystyna Elzbieta. "Extrusion and spheronization of microcrystalline cellulose and lactose mixtures." Thesis, University College London (University of London), 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.445344.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Zhang, Jinzhou. "Preparation and characterization of oxidized cellulose beads by extrusion/spheronization for chemoembolization." Diss., University of Iowa, 2013. https://ir.uiowa.edu/etd/2028.

Full text
Abstract:
Transarterial chemoembolization (TACE) has been practiced in patients for over 30 years and describes the infusion of chemotherapeutic agents followed by embolic particles. This infusion is normally performed by selecting tumor feeding arteries with a catheter under image guidance. The overall goal of TACE is to deliver a high dose of drug directly to a tumor, prevent drug clearance, and induce ischemic necrosis of the tumor. The limitations for current beads system including non-biodegradable and biodegradable beads used for TACE are low drug loading and only water soluble drug can be loaded in beads. The drug loading methods used in current beads system were ion-exchange method and expanding-loading-shrinking method, but these methods didn't allow loading high drug content (up to 10% drug loading) and water insoluble drug. The other limitation for current biodegradable beads used for TACE only had narrow size range beads. In those instances where treatment is not complete or the tumor recurs, physicians would like to be able to access a tumor on multiple occasions in order to administer additional TACE treatments as needed. It may not be possible to re-enter the feeding artery once this artery had been occluded by non-biodegradable beads. For overcoming above limitations, the goal in this study is developing a new biodegradable bead which should have wide size range, achieve high drug loading and high drug loading efficiency, and load water soluble and water insoluble drug. Extrusion/spheronization technology was chosen for drug loading method. It must be noted that not every polymer can be successfully extruded and spheronized. Oxidized cellulose (OC) was chosen in this study, which is biodegradable polymer. OC was evaluated as new excipient for extrusion/spheronization in this study. Differential scanning calorimetry (DSC) and dynamic vapor sorption analysis were used to compare the interaction and distribution of water within MCC and OC. The amounts of nonfreezing and freezing water in hydrated samples were determined from melting endotherms obtained by DSC. The moisture sorption profiles were analyzed according to the GAB equations. The adsorbed monolayer was not statistically different for MCC and OC after accounting for the amorphous content of the polymers. These results suggest that OC can act as a “molecular sponge,'' and thus aid in the production of beads by extrusion and spheronization. A composite central design was used to evaluate the influence of spheronizer speed, spheronizer time and water level (granulation liquid,) on pellet yield and sphericity. All factors as well as the interactions between water level and spheronizer speed were significant (P<0.05) for sphericity. And water level was significant (P<0.05) for pellet yield. The water insoluble drug, methotrexate (MTX), was used in this study. The drug content of OC and OC/carbopol beads was up to 40% and drug loading efficiency was 100%. The swelling ratio of the MTX loaded OC/carbopol beads were up to 200%, and the swelling ratio was decreased when drug content was increased. Comparing to commercial embolization produce Contour SE, OC and OC/carbopol beads were significantly more compressible. Recoverability of OC/carbopol beads is close to Contour SE. The beads stability increased with an increase in the MTX content. 100-900 μm beads could be delivered through from 18G to 23G needles. The release method involved the use of a T-Apparatus where the drug experiences an element of diffusion through a static environment. This method was developed to resemble the in -vivo situation in embolization procedures more closely. Release results showed from 57% to 78% MTX was released from OC/carbopol beads in 6 days depending on the drug content. OC as new pelletization aid can be used to produce beads by using extrusion/spheronization. The new biodegradable OC base beads have wide size range, achieve high drug loading (up to 40%) and high drug loading efficiency, and are able to load water soluble and water insoluble drug. Physical and mechanical properties of MTX loaded OC base beads match the requirement for catheter deliverability. The result of release study showed slow release. The biodegradable OC base beads are suitable for TACE.
APA, Harvard, Vancouver, ISO, and other styles
3

Pather, Sathasivan Indiran. "An investigation of the production of non-coated sustained release beads by extrusion and Spheronization." University of the Western Cape, 1995. http://hdl.handle.net/11394/8457.

Full text
Abstract:
Doctor Pharmaceuticae - DPharm
The popularity and increasing complexity of sustained release dosage forms has resulted in increased costs to the patient. One approach to achieve cheaper, yet effective, sustained release medication is through the simplification of production processes. Matrix tablets have been used to sustain the release of numerous drugs and are cheap to prepare. Since they are single-unit dosage forms, however, they display less predictable transit through the gastrointestinal tract. Hence, they provide less reliable blood levels of the drug in comparison with multi particulate dosage forms. Of the various types of multiparticulates available, pellets are popular for oral administration. A fairly recent innovation, in pelletization technology, is extrusion and spheronization. With this technique it is possible to produce pellets with a high degree of drug loading directly and rapidly. The drug loaded beads are usually coated for a sustained release effect. If one could omit the coating step, it would avoid many problems (thus reducing the number of quality control procedures required) and save chemicals, labour and capital for the purchase of additional equipment. The primary aim of this project was to investigate the preparation of non-coated, spheronized sustained release pellets, while a secondary aim was to prepare beads that can be compressed into sustained release tablets. A tablet can accommodate a larger mass and the compaction forces involved may enhance the sustained release effect. Several techniques were used in an attempt to sustain the release of drugs of different solubilities. In one series of formulations, a novel method was used to incorporate a binder consisting of ethylcellulose in ethanol. Using this technique, the release of Theophylline was sustained for approximately 8 hours. In other formulations, several materials were added to beads with the aim of forming sustained release matrixes. Only magnesium stearate was able to prolong the release of Acetaminophen and Theophylline for a reasonable time. In an attempt to explain why materials that were successfully used in sustained release matrix tablets were of very limited value in beads, an equation was developed to calculate the approximate distance between the retardant particles. Calculations using this equation revealed that the retardant particles were too far apart, within each bead, to expect consolidation to occur. The discrete retardant particles do not retard drug release effectively. Eudragit?-containing beads, which sustained the release of the drug to a small extent, were successfully compressed into tablets, both on their own and in combination with non pareil seeds. In each case, the sustained release effect was improved by compaction. In the case of the products manufactured with non pareil seeds, the tablets disintegrated rapidly to release the beads, thus ensuring that the advantages of multiparticulates were maintained. Because it was realised that a large amount of the matrix material could not be incorporated within the beads if a high dose drug was formulated with Avicel? PH 101, the idea of forming the matrix outside the beads was developed. Several materials were tried in an attempt to form a sustained release external matrix. Eudragit? RSPO prolonged the dissolution of Theophylline for more than four hours. Magnesium stearate was able to sustain the release of Acetaminophen and Theophylline appreciably. In the latter case, the dissolution, in water, of a standard adult dose of the drug was prolonged for more than 12 hours. However, the dissolution in an acidic medium was much faster. The described technique represents an advance in extrusion and spheronization technology. While beads containing Cutina? HR did not show promise as sustained release units, they compacted to form sustained release tablets of good appearance and acceptable strength. These tablets were considered to have been efficiently prepared because the constituent beads were easily manufactured and showed good flowability, and because a glidant and a lubricant were not required. The production of sustained release Indomethacin beads with a more steady release profile than the innovator's product has also been described in other experiments. The research described in this thesis represents progress towards the widespread commercial production of effective non-coated sustained release beads and may encourage further work towards this goal.
APA, Harvard, Vancouver, ISO, and other styles
4

Tomer, Gil. "An investigation of the role of water in the process of extrusion/spheronization of model formulations." Thesis, University College London (University of London), 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.391823.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Chatchawalsaisin, Jittima. "The influence of hydrophobic additives on the formation and drug release from pellets prepared by extrusion/spheronization." Thesis, University College London (University of London), 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.299281.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Chinyemba, Patience. "Use of Aloe vera and Aloe marlothii materials as excipients in beads produced by extrusion-spheronization / Patience Chinyemba." Thesis, North-West University, 2012. http://hdl.handle.net/10394/9641.

Full text
Abstract:
Microcrystalline cellulose (MCC) is the most commonly used excipient in the manufacture of spherical particles or beads by extrusion spheronisation. However, the use of MCC in beads has its limitations such as prolonged release of drugs due to lack of disintegration. The aim of this study was to determine if Aloe vera and Aloe marlothii leaf materials can be used as excipients in the production of beads prepared by extrusion spheronisation. A 23 full factorial design was employed for optimisation and to explore the effects of the concentration of MCC, polyvinylpyrrolidone and aloe materials on the sphericity and release rate of ketoprofen. Scanning electron microscopy revealed more porous beads when aloe materials were included in the bead formulations compared to the formulation with MMC alone. The bead formulations containing aloe materials exhibited faster drug release compared to that of the formulation containing MCC alone. Dissolution data of the optimised formulations were analysed in terms of mean dissolution time (MDT) as well as fit factors (f1 and f2). The optimised bead formulations had dissolution profiles comparable to that of the formulation containing MCC alone at pH 1.2 and 4.5 (f2 values > 70), but less comparable to the reference at pH 6.8 (50 < f2< 65) due to faster drug release. Aloe vera and Aloe marlothii leaf materials can be used successfully together with MCC in the production of beads by extrusion spheronisation.
Thesis (MSc (Pharmaceutics))--North-West University, Potchefstroom Campus, 2013.
APA, Harvard, Vancouver, ISO, and other styles
7

Nguyen, Thi Trinh Lan. "Extrusion- spheronization of pharmaceutical products : system for the delivery of active ingredients which are poorly soluble by oral route." Thesis, Strasbourg, 2017. http://www.theses.fr/2017STRAF047/document.

Full text
Abstract:
L'amélioration de la dissolution des médicaments peu solubles présente de nombreux défis.Dans cette thèse, un procédé d'extrusion-sphéronisation a été étudié en profondeur pour améliorer la dissolubilité du médicament avec une formulation de nano-émulsion. Le but du travail de thèse est de décrire les propriétés et les procédés de fabrication de minigranules permettant d'augmenter la solubilité des principes actifs peu solubles dans l'eau et donc d‘améliorer leur biodisponibilité lors de l'administration par voie orale, pour deux modèles de molécules différentes qui sont l‘acide folique (vitamine peu soluble dans l'eau) et le kétoprofène (anti-inflammatoire non stéroïdien qui présente une solubilité limitée dans les fluides gastriques à cause de son pKa (classe II dans le système de classification biopharmaceutique – BCS, ayant une action anti-inflammatoire, antalgique et antipyrétique). Cette étude décrit la préparation par extrusion-sphéronisation, caractérisation et étude de dissolution in vitro d'acide folique et de pastilles de kétoprofène revêtues de Acryl-EZE®, Advantia® Performance dans un minicoatère à lit fluidisé. Les résultats des essais ont montré la faisabilité de la préparation de pastilles enrobées entériques contenant un AINS et que, en revêtant le système multiparticulaire avec Acryl-EZE® 93A92545 et Advantia® Performance190024HA49 à un gain pondéral de 17,5%, 12,0%, respectivement, du médicament à partir des pastilles peuvent être obtenus. Les résultats des essais de dissolution ont indiqué que dans un milieu acide, le revêtement de film a entraîné un retard dans la libération du médicament, alors qu'aucun retard n'a été observé dans un milieu tampon à pH 6,8
Improvement in dissolution of poorly soluble drugs has many challenges.In this thesis, an extrusion-spheronization process was thoroughly studied forimproving dissolubility of drug with nano-emulsion formulation.The aim of the thesis work is to describe the properties and manufacturing processes ofpellets to increase the solubility of poorly soluble active ingredients in water and thus improvetheir bioavailability when administered orally: folic acid (water-insoluble vitamin) andketoprofen (Non-steroidal anti-inflammatory, having anti-inflammatory, analgesic andantipyretic action, class II in the Biopharmaceutical Classification System).This study describes the preparation by extrusion-spheronization, characterisation andin vitro dissolution study of folic acid and ketoprofen pellets. Ketoprofen pellets coated withAcryl-EZE®, Advantia® Performance in a fluid-bed minicoater. The results of the tests showedthe feasibility of the preparation of enteric-coated pellets containing a NSAID and that bycoating the multiparticulate system with either 17.5% Acryl-EZE® 93A92545 or with 12%Advantia® Performance 190024HA49 weight gain, an enteric release of the drug from thepellets can be obtained. The results of dissolution testing indicated that in acidic media, entericfilm coating resulted in a delay in the release of the drug, while no delay was observed in pH6.8 buffer media
APA, Harvard, Vancouver, ISO, and other styles
8

Abdalla, Ahmed Mohamed Effat M. [Verfasser], Karsten [Akademischer Betreuer] Mäder, Alfred [Akademischer Betreuer] Blume, and Michaela [Akademischer Betreuer] Schulz-Siegmund. "Development and characterization of self-emulsifying pellets by extrusion, spheronization / Ahmed Mohamed Effat Mohamed Abdalla. Betreuer: Karsten Mäder ; Alfred Blume ; Michaela Schulz-Siegmund." Halle, Saale : Universitäts- und Landesbibliothek Sachsen-Anhalt, 2008. http://d-nb.info/1024859045/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Silva, Filho Omar Paulino. "Obtenção de pellets a partir dos extratos líquidos padronizados de Brosimum gaudichaudii Trécul (Moraceae) ou Lafoensia pacari A. St.-Hil. (Lythraceae)." Universidade Federal de Goiás, 2014. http://repositorio.bc.ufg.br/tede/handle/tede/7463.

Full text
Abstract:
Submitted by JÚLIO HEBER SILVA (julioheber@yahoo.com.br) on 2017-06-13T20:14:26Z No. of bitstreams: 2 Dissertação - Omar Paulino da Silva Filho - 2014.pdf: 773195 bytes, checksum: 68a3f309ec2cd70a400359919399ad6b (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)
Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2017-06-14T15:25:01Z (GMT) No. of bitstreams: 2 Dissertação - Omar Paulino da Silva Filho - 2014.pdf: 773195 bytes, checksum: 68a3f309ec2cd70a400359919399ad6b (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)
Made available in DSpace on 2017-06-14T15:25:02Z (GMT). No. of bitstreams: 2 Dissertação - Omar Paulino da Silva Filho - 2014.pdf: 773195 bytes, checksum: 68a3f309ec2cd70a400359919399ad6b (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Previous issue date: 2014-07-11
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES
Pellets are spherical solid oral dosage forms that can be used in the development of new pharmaceutical products with standardized plant extracts. Brosimum gaudichaudii Trécul (Moraceae) and Lafoensia pacari A. St.-Hil. (Lythraceae) are typical species from the Cerrado biome. The extract obtained from the roots of B. gaudichaudii is traditionally used in the treatment of vitiligo, its effectiveness is due to the presence of the chemical markers psoralen and bergapten. As for L. pacari, the barks of the branches and trunk are traditionally used in the treatment of gastric ulcers, highly valued for there anti-inflammatory and wound healing because of there ellagic acid content. For each of these species optimal extractive methods exist to obtain standardized liquid extracts. However there are no studies that propose the development of solid oral dosage forms from them. Thus, the present study is aimed at obtaining pellets from the standardized liquid extract of the B. gaudichaudii roots, furthermore to determine the efficiency of a photoprotector coating on the stability of psoralen and bergapten and also obtaining pellets with standardized liquid extract of the L. pacari barks from the branches and trunk. The B. gaudichaudii roots were collected in the city of Jussara, Goiás, and the L. pacari barks in Niquelândia, Goiás. Separately, the raw materials were cleaned, dried in an oven with forced air circulation, then subsequently milled for the extractive process. After the standard liquid extract of B. gaudichaudii had been obtained, six formulas were developed at bench scale. Among these, one stood out by the homogeneity of the lot and the sphericity of its pellets. This formula had been selected to be sacaled-up and it`s composition had been formed by 49.5% (w/w) of microcrystalline cellulose (MCC), 1% (w/w) of hydroxypropylmethyl cellulose (HPMC) and 49.5% (w/w) of that extract. The pellets obtained from the scaled formula were divided into two portions, one of them had been coated with a photoprotective layer and both were subjected to a photostability test. The degradation of the markers had been evident only in the uncoated pellets. The reduction of 1.87% (w/w) in the content of psoralen and 8.1% (w/w) in bergapten content had been observed after 3 J/cm2 exposure to UVB radiation. After exposing to 30 J/cm2 of UVA, there had been a reduction of 24.1% (w/w) of psoralen and 28.48% (w/w) of bergapten. Therefore, the application of the photoprotective coating had been an effective alternative and ensured the stability of the chemical markers after the test. With respect to the liquid extract of L. pacari, 13 formulas were obtained among which only two formed pellets whose batch homogeneity had been greater than 70%. Among them, only one had been chosen to obtain the first scaled-up model. With the production of the scaled-up batch, it had been observed that formulas prepared with a lower proportion of standardized liquid extract of L. pacari had enabled us to obtaing more homogeneous, spherical and a smoother pellets. Based on these results and due to the innovative character of the studies, this work can be used as a model for future trials designed to obtain pellets with standardized liquid extract of B. gaudichaudii or L. pacari.
Pellets são formas farmacêuticas sólidas orais esféricas que podem ser utilizadas no desenvolvimento de novos produtos farmacêuticos a partir de extratos vegetais padronizados. Brosimum gaudichaudii Trécul (Moraceae) e Lafoensia pacari A. St.-Hil. (Lythraceae) são espécies típicas do bioma Cerrado. O extrato obtido das raízes de B. gaudichaudii é utilizado tradicionalmente no tratamento de vitiligo, cuja eficácia se deve pela presença dos marcadores químicos psoraleno e bergapteno. Quanto à espécie L. pacari, são tradicionalmente utilizados as cascas dos galhos e do tronco no tratamento de úlceras gástricas, cuja ação anti-inflamatória e cicatrizante é atribuída ao ácido elágico. Para cada uma destas espécies existem métodos extrativos otimizados para obtenção de extratos líquidos padronizados nos respectivos marcadores químicos. No entanto, não há estudos que proponham o desenvolvimento de formas farmacêuticas sólida orais a partir destes. Assim, o presente trabalho teve como objetivo obter pellets a partir do extrato hidroalcoólico das raízes de Brosimum gaudichaudii, padronizado em psoraleno e bergapteno, determinar a eficácia do revestimento fotoprotetor na estabilidade do psoraleno e bergapteno, além de obter pellets com o extrato hidroalcoólico das cascas dos galhos e do tronco de Lafoensia pacari, padronizado em ácido elágico. As raízes de B. gaudichaudii foram coletadas no município de Jussara, Goiás, e as cascas dos galhos e do tronco de L. pacari em Niquelândia, Goiás. Separadamente, as matérias-primas vegetais foram limpas, secas em estufa com circulação forçada de ar, posteriormente trituradas para a obtenção dos respectivos extratos líquidos padronizados. A partir do extrato líquido padronizado de B. gaudichaudii, foram obtidas seis fórmulas em escala de bancada. Dentre estas, uma se destacou pela homogeneidade do lote e pela esfericidade dos pellets. Deste modo, a fórmula que se destacou foi selecionada e escalonada, sua composição é formada pela mistura de XX% (m/m) de celulose microcristalina (CMC), X% (m/m) de hidroxipropilmetilcelulose (HPMC) e 49,5% deste extrato. Os pellets obtidos a partir da fórmula escalonada foram divididos em duas partes, em uma foi aplicado o revestimento fotoprotetor e ambas foram submetidas ao ensaio de fotoestabilidade. Desse modo, a degradação dos marcadores foi evidente apenas nos pellets sem o revestimento, cuja redução de no teor de psoraleno e bergapteno foi igual a 1,87% (m/m) e 8,1% (m/m), após a exposição a 3 J/cm2 de radiação UVB. Após a exposição a 30 J/cm2 de UVA, houve a redução de 24,1% (m/m) de psoraleno e 28,48% (m/m) de bergapteno. Portanto, a aplicação do revestimento fotoprotetor foi uma alternativa eficaz e garantiu a estabilidade dos marcadores químicos após o ensaio. Com relação ao extrato líquido de L. pacari, foram obtidas 13 fórmulas, dentre as quais apenas duas formaram pellets cuja homogeneidade dos lotes foi superior a 70% e apenas uma foi escolhida como modelo para a obtenção do lote piloto. Com a produção do lote piloto foi observado que fórmulas elaboradas com menor proporção do extrato padronizado de L. pacari e a mecanização do processo de mistura dos componentes da fórmula, possibilitam a obtenção de pellets mais esféricos, homogêneos e com superfície menos irregular. Diante dos resultados obtidos e devido ao caráter inovador dos estudos realizados, este trabalho pode ser utilizado como modelo para ensaios futuros destinados a obtenção de pellets com o extrato líquido padronizado de B. gaudichaudii ou L. pacari.
APA, Harvard, Vancouver, ISO, and other styles
10

Kratz, Cristiane de Pellegrini. "Obtenção de comprimidos contendo grânulos deformantes e grânulos revestidos gastro-resistentes." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2002. http://hdl.handle.net/10183/147657.

Full text
Abstract:
Sistemas monolíticos particulados contendo os constituintes ativos veiculados na forma de grânulos revestidos - pellets - têm recebido crescente atenção nos últimos anos, em função da otimização na biodisponibilidade e segurança na liberação do fármaco. A utilização destas unidades, como componentes de comprimidos traz, como principal vantagem, a divisibilidade da forma sem a perda do perfil biofarmacêutico desejado para o fármaco. Para sua produção, é indispensável a manutenção da integridade do revestimento daquelas unidades. Uma estratégia para o alcance deste objetivo envolve a utilização de grânulos inertes deformantes, comprimidos em conjunto com os grânulos revestidos, que atuam como um sistema de amortecimento das forças de compressão. Neste trabalho investigou-se a produção de grânulos deformantes através de dois métodos de granulação por via úmida, avaliando a influência de adjuvantes sobre as características dos produtos obtidos. Empregando a técnica de extrusão/esferonização obtiveram-se grânulos com propriedades de fluxo, empacotamento e resistência mecânica aceitáveis. O efeito dos adjuvantes sobre as etapas tecnológicas foi estudado por meio de um planejamento fatorial. Testaram-se duas variedades de celulose microcristalina, os desintegrantes croscarmelose sódica e crospovidona e soluções aglutinantes aquosas e hidroetanólicas de povidona. Para o desenvolvimento dos comprimidos utilizaram-se, como modelo, grânulos revestidos gastro-resistentes contendo omeprazol. A influência da composição dos grânulos deformantes sobre a liodisponibilidade do fármaco dos comprimidos foi avaliada através de análise fatorial 23. Os grânulos deformantes protegeram o revestimento polimérico dos pellets com diferentes intensidades.
Monolythic particulate systems containing the active constituents as coated pellets became great interest due to the improvement of safety and bioavailability. The use of such units as components of tablets shows as main advantages the divisibility of the pharmaceutical dosage form without loosing the desired biopharmaceutical profile of the drug. Consequently for the tablet production, the integrity of the polymeric film must be attained. A strategic option involves the utilization of inert soft pellets, which could be compressed together with the film coated pellets, absorbing the compaction forces. In this work the production of soft pellets was investigated using two wet granulation methods and evaluating the influence of formulation adjuvants on the pellets properties. The extrusion/spheronization technique yielded pellets with acceptable flow, packing and mechanical characteristics. The influence of the adjuvants on the technological steps was carried out through a statistical designed experiment. Microcrystalline cellulose from two producers, the disintegrants sodium croscarmellose and crospovidone, and aqueous and hydroethanolic dispersions of povidone, as binder, were tested. For the tablets development omeprazol gastroresistant film coated pellets were used as model. Aiming at the study of the influence of the soft pellets composition on drug lyoavailability was performed a 23 factorial experiment. The soft pellets protected at different intensities the polymeric coating of the gastroresistant pellets.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Extrusion-spheronization"

1

Nguyen, Thi Trinh Lan, Nicolas Anton, and Thierry F. Vandamme. "Nutraceutical compounds encapsulated by extrusion-spheronization." In New Polymers for Encapsulation of Nutraceutical Compounds, 195–230. Chichester, UK: John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119227625.ch9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Erkoboni, David F. "Extrusion/Spheronization as a Granulation Technique." In Handbook of Pharmaceutical Granulation Technology, 409–43. 4th ed. Fourth edition. | Boca Raton, FL : CRC Press, 2021. | Series: Drugs and the pharmaceutical sciences: CRC Press, 2021. http://dx.doi.org/10.1201/9780429320057-12-14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Thommes, Markus, and Peter Kleinebudde. "The Science and Practice of Extrusion-Spheronization." In Advances in Delivery Science and Technology, 37–63. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7012-4_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Natarajan, Jawahar, and Veera Venkata Satyanarayana Reddy Karri. "Formulation and Comparison of Lipophilic Drugs Through Self-Emulsifying Pellets Using Extrusion–Spheronization Technique." In Nanoparticles in Polymer Systems for Biomedical Applications, 176–202. Oakville, Canada ; Waretown, NJ : Apple Academic Press, [2019]: Apple Academic Press, 2018. http://dx.doi.org/10.1201/9781351047883-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Villar-López, M. E., F. Otero-Espinar, and J. Blanco-Méndez. "Preparation by Extrusion/Spheronization of Triamcinolone / ß-Cyclodextrin Pellets as a Fast Release Dosage Form." In Proceedings of the Ninth International Symposium on Cyclodextrins, 483–86. Dordrecht: Springer Netherlands, 1999. http://dx.doi.org/10.1007/978-94-011-4681-4_115.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

"Extrusion/Spheronization." In Pharmaceutical Extrusion Technology, 296–341. CRC Press, 2003. http://dx.doi.org/10.1201/9780203911532-18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Erkoboni, David. "Extrusion/Spheronization." In Drugs and the Pharmaceutical Sciences. Informa Healthcare, 2003. http://dx.doi.org/10.1201/9780203911532.ch15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Iyer, Raman, Navnit Shah, Wantanee Phuapradit, Harpreet Sandhu, and Hashim Ahmed. "Scale-Up of Extrusion and Spheronization." In Drugs and the Pharmaceutical Sciences, 325–69. Informa Healthcare, 2005. http://dx.doi.org/10.1201/9781420026658.ch11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

"Extrusion/Spheronization as a Granulation Technique." In Handbook of Pharmaceutical Granulation Technology, 361–92. CRC Press, 2005. http://dx.doi.org/10.1201/9780849354953-14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Mehta, Ketan, Gurvinder Singh Rekhi, and Dilip Parikh. "Extrusion/Spheronization as a Granulation Technique." In Drugs and the Pharmaceutical Sciences, 333–64. Informa Healthcare, 2005. http://dx.doi.org/10.1201/9780849354953.ch11.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Extrusion-spheronization"

1

Ibrahim, Yousif, Katalin Kristó, Géza Regdon, and Tamás Sovány. "Effect of Processing Conditions and Material Attributes on the Design Space of Lysozyme Pellets Prepared by Extrusion/Spheronization." In II. Symposium of Young Researchers on Pharmaceutical Technology,Biotechnology and Regulatory Science. Szeged: Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 2020. http://dx.doi.org/10.14232/syrptbrs.2020.op34.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Extrusion-spheronization"

1

Dimitrov, Milen, and Teodora Popova. Technological and Biopharmaceutical Characterization of Ethylcellulose-based Pellets with Montelukast Sodium Prepared via Wet Extrusion and Spheronization. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, May 2018. http://dx.doi.org/10.7546/crabs.2018.05.06.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography